We are thrilled to announce the publication of the first-in-human study on Neurocritical Care. Our group has developed a technology – CB240_Aurora – that allows selective brain temperature management with a highly portable device, thus maximizing neuroprotection while minimizing systemic side effects. Thanks to its portability, the technology may also allow the early application of […]
Read MoreA Novel Technology for Targeted Brain Temperature Management
Posted by Mary Franzese | news | July 28, 2023